using because it is safe!!!, page-2

GM-

The process of getting an article peer-reviewed and published is a long and tedious process. The data presented last spring at the Edinburgh International Burns Conference only appears in the Journal of Burn Care in January 2013.

There have been any number of papers published over the years regarding the biological action of AOD9604, and more are coming. The results of the Korean studies will be published in detail in due course, and I'm sure that there will be further papers from Dr. Grynpas. There isn't any reason to think that safety data on AOD9604 won't find a publisher. I'm quite sure that at least one paper has been prepared, maybe more, and that the process to get one or more published is also underway at some stage.

But the company certainly would have nothing to announce until a paper has been accepted for publication, and that obviously has not happened yet. Until it does, the GRAS process is not complete and AOD9604 can't be used in nutritional supplements. That all changes upon publication.

It is also reasonable to assume that there has been discussion regarding potential uses in the nutritional supplement field. None of these initiatives can come to fruition until the GRAS process has been completed by the publication of the safety data. This is only a matter of time.

Meanwhile, I imagine that there isn't any notion that the company can take AOD9604 through human trials to approval as a pharmaceutical on its own. This will require a partner. Will one come forward? I have no idea, but the chances of that happening were certainly helped by the Korean results.

I would like to be able to offer some sort of timeline for publication of the AID9604 safety data, but I don't have one. I would assume that it could be several more months, though. As I said, I the process is very lengthy.